|4Feb 25, 5:00 PM ET

Sagent Pharmaceuticals, Inc. 4

4 · Sagent Pharmaceuticals, Inc. · Filed Feb 25, 2016

Insider Transaction Report

Form 4
Period: 2016-02-25
Drake Lorin
VP, Sales and Marketing
Transactions
  • Tax Payment

    Common Stock

    2016-02-25$14.58/sh335$4,88439,172 total

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT